Inhibition of human telomerase reverse transcriptase in hep-2 cells using short hairpin RNA expression vectors

Archives of Otolaryngology - Head and Neck Surgery

Volumn 132, Issue 2, 2006, Pages 200-205

  Chen, Shi Ming ^a   Tao, Ze Zhang ^a   Hua, Qing Quan ^a   Liu, Dan ^a   Chi, Hua Ming ^a   Cai, Qing ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL THIZOL 2 YL) 2,5 DIPHENYL TETRAZOLIUM BROMIDE; BROMINE DERIVATIVE; MESSENGER RNA; SHORT HAIRPIN RNA; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; HEP 2 CELL; HUMAN; HUMAN CELL; LARYNX CANCER; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CATALYTIC DOMAIN; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; LARYNGEAL NEOPLASMS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, CATALYTIC; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE;

EID: 33644829061     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.2.200     Document Type: Article

References (26)

1. Masutomi K, Yu EY, Khurts S, et al. Telomerase maintains telomere structure in normal human cells. Cell. 2003;114:241-253.
2. Smolikov S, Mazor Y, Krauskopf A. ELG1, a regulator of genome stability, has a role in telomere length regulation and in silencing. Proc Natl Acad Sci U S A. 2004;101:1656-1661.
3. Stewart SA. Multiple levels of telomerase regulation. Mol Interv. 2002;2:481-483.
4. Boldrini L, Faviana P, Gisfredi S, et al. Regulation of telomerase and its hTERT messenger in colorectal cancer. Oncol Rep. 2004;11:395-400.
5. Guilleret I, Benhattar J. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res. 2003;289:326-334.
6. Simonsen JL, Rosada C, Serakinci N, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002;20:592-596.
7. Reddel RR. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett. 2003;194:155-162.
8. Luzar B, Poljak M, Marin IJ, et al. Quantitative measurement of telomerase catalytic subunit (hTERT) RNA in laryngeal squamous cell carcinomas. Anticancer Res. 2001;21:4011-4055.
9. Curran AJ, Gullane PJ, Irish J, et al. Telomerase activity is upregulated in laryngeal squamous cell carcinoma. Laryngoscope. 2000;110:391-396.
10. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494-498.
11. Zamore PD. RNAi: double-stranded RNA directs the ATP dependent cleavage of mRNA at 21-23 nucleotide intervals. Cell. 2000;101:25-33.
12. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296:550-553.
13. Paul CP, Good PD, Winer I, et al. Effective expression of small interfering RNA in human cells. Nat Biotechnol. 2002;20:505-508.
14. Liu XD, Ma SM, Liu Y, et al. Short hairpin RNA and retroviral vector-mediated silencing of p53 in mammalian cells. Biochem Biophys Res Commun. 2004;324:1173-1178.
15. Zhang DL, Zhang YT, Yin JJ, et al. Oral administration of crataegus flavonoids protects against ischemia/reperfusion brain damage in gerbils. J Neurochem. 2004;90:211-219.
16. McCaffrey AP, Meuse L, Pham TT, et al. RNA interference in adult mice. Nature. 2002;418:38-39.
17. Hemann MT, Fridman JS, Zilfou JT, et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet. 2003;33:396-400.
18. Yu JY, Taylor J, DeRuiter SL, et al. Simultaneous inhibition of GSK3α and GSK3β using hairpin siRNA expression vectors. Mol Ther. 2003;7:228-236.
19. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001;15:188-200.
20. Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 2001;20:6877-6888.
21. Holen T, Amarzguioui M, Wiiger MT, et al. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 2002;30:1757-1766.
22. Paddison PJ, Caudy AA, Bernstein E, et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 2002;16:948-958.
23. Mittal A, Pate MS, Wylie RC, et al. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol. 2004;24:703-710.
24. Kang MK, Kameta A, Shin KH, et al. Senescence occurs with hTERT repression and limited telomere shortening in human oral keratinocytes cultured with feeder cells. J Cell Physiol. 2004;199:364-370.
25. Wang Q, Bai Z, Li X, et al. The evidences of human orphan receptor COUP-TFII inhibiting telomerase activity through decreasing hTERT transcription. Cancer Lett. 2004;214:81-90.
26. Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis. 2003;24:1167-1176.